Invested in Flomics, a Barcelona liquid-biopsy multi-cancer early detection biotech.
Flomics is a biotechnology company operating in the genomics and liquid biopsy space
Flomics is a biotechnology company operating in the genomics and liquid biopsy space. By combining Next-generation sequencing (NGS) technology with machine learning, we developed a liquid biopsy test that can provide clinically relevant information for the early detection and management of cancer and other complex diseases. Everything from a blood sample.